Dogwood Therapeutics Statistics
Total Valuation
DWTX has a market cap or net worth of $41.29 million. The enterprise value is $36.46 million.
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DWTX has 38.23 million shares outstanding. The number of shares has increased by 1,665.19% in one year.
| Current Share Class | 38.23M |
| Shares Outstanding | 38.23M |
| Shares Change (YoY) | +1,665.19% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 2.91% |
| Float | 6.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 412.86 |
| Forward PS | n/a |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 364.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.78 |
| Quick Ratio | 2.28 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.58% and return on invested capital (ROIC) is -16.40%.
| Return on Equity (ROE) | -35.58% |
| Return on Assets (ROA) | -13.88% |
| Return on Invested Capital (ROIC) | -16.40% |
| Return on Capital Employed (ROCE) | -25.34% |
| Weighted Average Cost of Capital (WACC) | 15.83% |
| Revenue Per Employee | $12,500 |
| Profits Per Employee | -$3.15M |
| Employee Count | 8 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.95% in the last 52 weeks. The beta is 2.11, so DWTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.11 |
| 52-Week Price Change | -80.95% |
| 50-Day Moving Average | 1.34 |
| 200-Day Moving Average | 1.86 |
| Relative Strength Index (RSI) | 39.95 |
| Average Volume (20 Days) | 111,276 |
Short Selling Information
The latest short interest is 111,693, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 111,693 |
| Short Previous Month | 62,406 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 1.82% |
| Short Ratio (days to cover) | 1.56 |
Income Statement
In the last 12 months, DWTX had revenue of $100,000 and -$25.18 million in losses. Loss per share was -$0.87.
| Revenue | 100,000 |
| Gross Profit | 11,896 |
| Operating Income | -18.61M |
| Pretax Income | -27.63M |
| Net Income | -25.18M |
| EBITDA | -18.61M |
| EBIT | -18.61M |
| Loss Per Share | -$0.87 |
Full Income Statement Balance Sheet
The company has $4.95 million in cash and $117,950 in debt, with a net cash position of $4.83 million or $0.13 per share.
| Cash & Cash Equivalents | 4.95M |
| Total Debt | 117,950 |
| Net Cash | 4.83M |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | 64.13M |
| Book Value Per Share | 1.88 |
| Working Capital | 3.87M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -16.47M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1,547 |
| Net Borrowing | n/a |
| Free Cash Flow | -16.47M |
| FCF Per Share | -$0.43 |
Full Cash Flow Statement Margins
| Gross Margin | 11.90% |
| Operating Margin | -18,608.44% |
| Pretax Margin | -27,628.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DWTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,665.19% |
| Shareholder Yield | -1,665.19% |
| Earnings Yield | -80.09% |
| FCF Yield | -39.90% |
Analyst Forecast
The average price target for DWTX is $14.00, which is 1,196.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 1,196.30% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 9, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Oct 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
DWTX has an Altman Z-Score of 0.59 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.59 |
| Piotroski F-Score | 1 |